glp-1 drugs alzheimer's Disappointing Results in Trial: Underscores Promise (and Limits) of Single-Agent Approaches Alzheimer's: Ozempic and Similar Drugs

The trial aimed to evaluate both acute effects on ICP as well as effects over a 3-month time horizon

2.3%) and there was no difference in the percentage of participants with acute pancreatitis or malignant neoplasms between the two groups [110]

Please talk with your doctor about the risks and side effects before starting any GLP-1 medication

While we have not tested the full combination in females, we have tested GDF8 and ActA blockade in lean female monkeys 28 and in postmenopausal women in our Phase 1 clinical study in the accompanying manuscript (Gonzalez Trotter et al

FDA (2024)

It is not FDA-approved for weight loss, but is often prescribed off-label by licensed providers to support appetite regulation, food craving reduction, and weight management